# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Adenoma of the Adrenal Gland

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 13 results.
Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas
Status: Recruiting
Last Changed: Oct 12, 2018
First Received: Feb 16, 2015
Disease(s): Adrenal Incidentalomas
Intervention(s): Laparoscopic surgical removal of the adrenal tumor, Standardized medical treatment of hypertension by SAHR
Locations: Service de Médecine Interne, Endocrinologie et Nutrition - CHU de Strasbourg, Strasbourg, Alsace, France
Service Endocrinologie, Diabétologie, maladies métaboliques - CHU de Bordeaux, Pessac, Aquitaine, France
Service d'Endocrinologie - Niveau 18 - Caen CHU Côte de Nacre, Caen, Basse-Normandie, France
Service d'Endocrinologie -Diabète-Nutrition - CHU de REIMS, Reims, Champagne-Ardenne, France
Service d'Endocrinologie, Diabétologie, Nutrition - CHU d'Amiens, Amiens, Haut De France, France
... and 23 other locations.
Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic Alterations
Status: Recruiting
Last Changed: Oct 15, 2019
First Received: Oct 15, 2019
Disease(s): Adrenal Incidentaloma, Hypercortisolism, Adrenal Tumor
Intervention(s): Adrenalectomy
Locations: Department of Experimental Medicine, Rome, Italy
Long-term Beneficial Metabolic Effects of Adrenalectomy in Subclinical Cushing's Syndrome of Adrenal Incidentaloma
Status: Recruiting
Last Changed: Apr 04, 2019
First Received: Jun 27, 2011
Disease(s): Cushing Syndrome
Intervention(s): surgery
Locations: Samsung Medical Center, Seoul, Korea, Republic of
Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield
Status: Recruiting
Last Changed: Jun 10, 2019
First Received: Dec 24, 2014
Disease(s): Adrenal Incidentaloma, Adrenocortical Carcinoma
Locations: University Medical Center Groningen, Groningen, Netherlands
Effect of Chronic Catecholamine Overproduction on Brown Adipose Tissue
Status: Recruiting
Last Changed: May 24, 2019
First Received: Sep 24, 2013
Disease(s): Pheochromocytoma, Adrenal Incidentaloma
Intervention(s): Removal of adrenal tumor
Locations: Department of Endocrinology MEA, Aarhus Hospital, Aarhus C, Please Select, Denmark
Radiofrequency Endoscopic Ablation With Ultrasound Guidance: a Non-surgical Treatment for Aldosterone-producing Adenomas
Status: Recruiting
Last Changed: May 25, 2018
First Received: Jan 19, 2018
Disease(s): Primary Hyperaldosteronism, Primary Hyperaldosteronism Due to Adrenal Adenoma
Intervention(s): Endoscopic ultrasound guided radiofrequency ablation, ultrasound
Locations: Queen Mary University of London, London, United Kingdom
University College London, London, United Kingdom
A Prospective Cohort Study for Patients With Adrenal Diseases
Status: Not yet recruiting
Last Changed: Sep 21, 2018
First Received: Mar 22, 2018
Disease(s): Adrenal Adenoma, Cushing Syndrome, Pheochromocytoma, Adrenal Incidentaloma, Adrenocortical Carcinoma, Primary Hyperaldosteronism
Intervention(s): Hormone study and Imaging study
Rapid Cortisol Assay in Adrenal Vein Sampling
Status: Not yet recruiting
Last Changed: Mar 09, 2018
First Received: Feb 28, 2018
Disease(s): Primary Aldosteronism Due to Aldosterone Producing Adenoma
Intervention(s): AVS performed with no intraprocedural rapid cortisol assay, AVS performed plus intraprocedural rapid cortisol assay
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
Status: Recruiting
Last Changed: Feb 28, 2020
First Received: Dec 15, 2017
Disease(s): Adrenal Gland Neoplasm, Hypertension, Bone Diseases, Metabolic, Cardiovascular Disease, Hyperinsulinemia
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome
Status: Recruiting
Last Changed: Nov 22, 2019
First Received: Oct 05, 2018
Disease(s): Cushing Syndrome
Intervention(s): Relacorilant, Placebo
Locations: Site 21, Phoenix, Arizona, United States
Site 36, Los Angeles, California, United States
Site 42, Santa Monica, California, United States
Site 9, Aurora, Colorado, United States
Site 32, Washington, District of Columbia, United States
... and 39 other locations.